Genetic association between the phospholipase A2 gene and unipolar affective disorder: A multicentre case-control study

Psychiatric Genetics

Volumn 13, Issue 4, 2003, Pages 211-220

  Papadimitriou, George N ^a,b   Dikeos, Dimitris G ^a,b   Souery, Daniel ^c   Del Favero, Jurgen ^d   Massat, Isabelle ^c   Avramopoulos, Dimitrios ^b   Blairy, Sylvie ^c   Cichon, Sven ^d   Ivezic, Sladjana ^e   Kaneva, Radka ^f   Karadima, Georgia ^b   Lilli, Roberta ^g   Milanova, Vihra ^f   Nöthen, Markus ^d   Oruc, Lilijana ^h   Rietschel, Marcella ⁱ   Serretti, Alessandro ^g   Van Broeckhoven, Christine ^d   Stefanis, Costas N ^b   Mendlewicz, Julien ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY MENTAL HEALTH RESEARCH INSTITUTE   (Greece)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e Psychiatric Hospital Vrap e   (Croatia)

^f UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

ⁱ UNIVERSITY OF BONN   (Germany)

Author keywords

Chromosome 12; Genetic association; Phospholipase A2 gene; PLA2; Unipolar affective disorder

Indexed keywords

DNA; PHOSPHOLIPASE A2;

ALLELE; ARTICLE; BELGIUM; BULGARIA; CASE CONTROL STUDY; CHROMOSOME 12Q; CONTROLLED STUDY; CROATIA; FEMALE; GENE SEGREGATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERMANY; GREECE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CHROMOSOME MAPPING; DEPRESSIVE DISORDER; EUROPE; FEMALE; GENE FREQUENCY; HUMANS; MALE; PHOSPHOLIPASES A;

EID: 0346961692     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200312000-00004     Document Type: Article

References (74)

1. Axelrod J, Burch RM, Jelsema CL (1988). Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci 11:117-123.
2. Baron M (1992). Molecular genetics of affective psychoses. In: Mendlewicz J, Hippius H, Bondy B, Ackenheil M, Sandler M (editors): Genetic Research in Psychiatry. Berlin: Springer-Verlag; pp. 1-17.
3. Baron M (2001). The search for complex disease genes: fault by linkage or fault by association? Mol Psychiatry 6:143-149.
4. Bashir R, Munro CS, Mason S, Stephenson A, Rees JL, Strachan T (1993). Localisation of a gene for Darier's disease. Hum Mol Genet 2:1937-1939.
5. Bertelsen A, Harvald B, Hauge M (1977). A Danish twin study of manic-depressive disorders. Br J Psychiatry 130:330-351.
6. Catania MV, Hollingsworth Z, Penney JB, Young AB (1993). Phospholipase A2 modulates different subtypes of excitation amino acids receptors: autoradiographic evidence. J Neurochem 60:236-245.
7. Comings DE (1994). Candidate genes and association studies in psychiatry. Am J Med Genet (Neuropsychiatr Genet) 54:324-325.
8. Craddock N, Dawson E, Burge S, Parfitt L, Mant B, Roberts Q, et al. (1993). The gene for Darier's disease maps to chromosome 12q23-q24.1, Hum Mol Genet 2:1941-1943.
9. Craddock N, Owen M, Burge S, Kurian B, Thomas P, McGuffin P (1994). Familial cosegregation of major affective disorder and Darier's disease (keratosis folicularis). Br J Psychiatry 164:355-358.
10. Crowe RR (1993). Candidate genes in psychiatry: an epidemiological perspective. Am J Med Genet (Neuropsychiatr Genet) 48:74-77.
11. Dawson E, Parfitt E, Roberts Q, Daniels J, Lim L, Sham P, et al. (1995a). Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1. Am J Med Genet 60:94-102.
12. Dawson E, Gill M, Curtis D, Castle D, Hunt N, Murray R, Powell J (1995b). Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder. Psychiatr Genet 5:177-180.
13. Degn B, Lundorf MD, Wang A, Vang M, Mors O, Kruse TA, Ewald H (2001). Further evidence for a bipolar risk gene on chromosome 12q24 suggested by investigation of haplotype sharing and allelic association in patients from the Faroe Islands. Mol Psychiatry 6:450-455.
14. Deicken RF, Weiner MW, Fein G (1995). Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 33:195-199.
15. Dennis EA (1994). Diversity of group types, regulation and function of phospholipase A2. J Biochem 269:13057-13060.
16. Dennis EA (1997). The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 22:1-2.
17. Dennis EA, Deems RA, Lin Y (1992). Extracellular phospholipase A2. In: Bazan NG, Murphy MG, Tofano G (editors): Neurobiology of Essential Fatty Acids. New York: Plenum Press; pp. 35-40.
18. 125l-labelled pancreatic secretory phospholipase A2 in rat brain. Mol Brain Res 49:120-126.
19. Endicott J, Spitzer RL (1978). A diagnostic interview. The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-862.
20. Ewald H, Degn B, Mors O, Kruse TA (1998). Significant linkage between bipolar affective disorder and chromosome 12q24. Psychiatr Genet 8:131-140.
21. Ewald H, Flint T, Kruse TA, Mors O (2002). A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22-21, 4p16, 6q14-22, 10q26 and 16p13.3. Mol Psychiatry 7:734-744.
22. Farmer AE, Cosyns P, Leboyer M, Mayer W, Mors O, Sargeant M, et al. (1993). SCAN-SADS comparison study of psychotic subjects and their first degree relatives. Eur Arch Psychiatry 242:352-357.
23. Farooqui AA, Hirashima Y, Horrocks LA (1992). Brain phospholipases and their role in signal tranduction. In: Bazan NG, Murphy MG, Tofano G (editors): Neurobiology of Essential Fatty Acids. New York: Plenum Press; pp. 11-26.
24. Faul F, Erdfelder E (1992). GPOWER: A priori, Post-Hoc, and Compromise Power Analyses for MS-DOS [computer program]. Bonn: Bonn University.
25. Fenton WS, Hibbeln J, Knable M (2000). Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47:8-21.
26. Fukuzako H (2001). Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonace spectroscopy. World J Biol Psychiatry 2:70-82.
27. Gattaz WF, Kollisch M, Thuren T, Virtanen JA, Kinnunen PK (1987). Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biol Psychiatry 22:421-426.
28. Gattaz WF, Hubner CV, Nevalainen TJ, Thuren T, Kinnunen PK (1990). Increased serum phospholipase A2 activity in schizophrenia: a replication study. Biol Psychiatry 28:495-501.
29. Gattaz WF, Schmitt A, Maras A (1995). Increased platelet phospholipase A2 activity in schizophrenia. Schizophr Res 16:1-6.
30. Hibbeln JR, Palmer JW, Davis JM (1989). Are disturbancess in lipid-protein interactions by phospholipase-A2 a predisposing factor in affective illness? Biol Psychiatry 25:109-110.
31. Hodge SE (1994). What association analysis can and cannot tell us about the genetics of complex disease. Am J Med Genet (Neuropsychiatr Genet) 54:318-323.
32. Hoglund M, Siden T, Aman P, Mandahl N, Mitelman F (1995). Isolation and characterization of radiation hybrids for human chromosome 12. Cytogenet Cell Genet 69:240-245.
33. Horrobin DF, Bennett CN (1999). New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 60:141-167.
34. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001). Replication validity of genetic association studies. Nat Genet 29:306-309.
35. Jacobsen N, Daniels J, Moorhead S, Harrison D, Feldman E, McGuffin P, et al. (1996). Association study of bipolar disorder at the phospholipase A2 gene (PLA2A) in the Darier's disease (DAR) region of chromosome 12q23-q24.1. Psychiatr Genet 6:195-199.
36. Jacobsen NJ, Franks EK, Owen MJ, Craddock NJ (1999). Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder. Mol Psychiatry 4:274-279.
37. Jacobsen NJ, Franks EK, Elvidge G, Jones I, McCandless F, O'Donovan MC, et al. (2001). Exclusion of the Darier's disease gene, ATP2A2, as a common susceptibility gene for bipolar disorder. Mol Psychiatry 6:92-97.
38. Jones I, Jacobsen NJ, Green EK, Elvidge GP, Owen MJ, Craddock NJ (2002). Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darrier's disease. Mol Psychiatry 7:424-427.
39. Kidd KK (1993). Associations of disease with genetic marker: deja vu all over again. Am J Med Genet (Neuropsychiatr Genet) 48:71-73.
40. Lerer B, Macciardi F, Segman RH, Adolfsson R, Blackwood D, Blairy S, et al. (2001). Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorders. Mol Psychiatry, 6:579-585.
41. Massat I, Souery D, Del-Favero J, Oruc L, Noethen M, Blackwood D, et al. (2002a). Excess of Allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study. Mol Psychiatry 7:201-207.
42. Massat I, Souery D, Del-Favero J, van Gestel S, Serretti A, Macciardi F, et al. (2002b). Positive association of dopamine receptor polymorphism with bipolar affective disorder in a European multicenter association study of affective disorders. Am J Med Genet 114:177-185.
43. Mendlewicz J (1988). Population and family studies in depression and mania. Br J Psychiatry 153(suppl 3):16-25.
44. Morissette J, Villneuve A, Bordeleau L, Rochette D, Lagerge C, Gagne B, et al. (1999). Genome-wide search for linkage of bipolar affective disorder in a very large pedigree derived from a homogeneous population in Quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 88:567-587.
45. Murray JC, Buetow KH, Weber JL, Ludwigsen S, Scherpbier-Heddema T, Manion F, et al. (1994). A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC). Science 265:2049-2054.
46. Noponen M, Sanfilipo M, Samanich K, Ryer H, Ko G, Angrist B, et al. (1993). Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry 34:641-649.
47. Oliveira CR, Duarte EP, Carvalho AP (1984). Effect of phospholipase digestion and lysophosphadylcholine on dopamine receptor binding. J Neurochem 43:455-465.
48. 2(+)- transporting ATPases to human chromosomes 1q25-32 and 12q21-23. Genomics 9:629-641.
49. Pappu A, Hostetler KY (1984). Effect of cationic amphiphilic drugs on the hydrolysis of acidic and neutral phospholipids by liver lysosomal phospholipase A. Biochem Pharmacol 33:1639-1644.
50. Polymeropoulos MH, Rath DS, Xiao H, Merril CR (1990). Trinucleotide repeat polymorphism at the human pancreatic phospholipase A-2 gene (PLA2). Nucleic Acids Res 18:7468.
51. Raymond M, Rousset F (1995). GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 86:248-249.
52. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, et al. (2001). Linkage disequilibrium in the human genome. Nature 411:199-204.
53. Rice JP, Rochberg N, Endicott J, Lavori PW, Miller C (1992). Stability of psychiatric diagnoses. An application to the affective disorders. Arch Gen Psychiatry 49:824-830.
54. Risch N, Merikangas K (1996). The future of genetic studies of complex human diseases. Science 273:1516-1517.
55. Ross BM, Hudson C, Erlich J, Warsh JJ, Kish SJ (1997). Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Arch Gen Psychiatry 54:487-494.
56. Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ (1999). Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Res 821:407-413.
57. 2+ pump, cause Darier disease. Nat Genet 21:271-277.
58. Scott WK, Pericak-Vance MA, Haines JL, Bell DA, Taylor JA, Long AD, et al. (1997). Genetic analysis of complex diseases. Science 275:1327-1330.
59. Seilhamer JJ, Randall TL, Yamanaka M, Johnson LK (1986). Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 5:519-527.
60. Seilhamer JJ, Randall TL, Johnson LK, Heinzmann C, Klisak I, Sparkes RS, Lusis AJ (1989). Novel gene exon homologous to pancreatic phospholipase A2: sequence and chromosomal mapping of both human genes. J Cell Biochem 39:327-337.
61. Sgaragli GP, Della Corte L, Gremigni D (1983). Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat. Pharmacol Res Commun 15:231-246.
62. Sham PC, Curtis D (1995). Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
63. Souery D, Papadimitriou GN, Mendlewicz J (1996). New molecular genetic studies in affective disorders. In: Papadimitriou GN, Mendlewicz J (editors): Genetics of Mental Disorders. Part II: Clinical Issues. Bailliere's Clinical Psychiatry. London: Bailliere Tindall; pp. 1-13.
64. Souery D, Lipp O, Mahieu B, Serreti A, Cavallini C, Ackenheil M, et al. (1998). European collaborative project on affective disorders: interactions between genetic and psychosocial vulnerability factors. Psychiatr Genet 8:197-205.
65. Souery D, van Gestel S, Massat I, Blairy S, Adolfsson R, Blackwood D, et al. (2001). Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry, 49:405-409.
66. Spector AA, Yorek MA (1985). Membrane lipid composition and cellular function. J Lipid Res 26:1015-1035.
67. Stefanis CN, Dikeos DG, Papadimitriou GN (1995). Clinical strategies in genetic research. In: Mendlewicz J, Papadimitriou GN (editors): Genetics of Mental Disorders. Part I: Theoretical Aspects. Bailliere's Clinical Psychiatry. London: Bailliere Tindall; pp. 1-18.
68. Sun GY, Bazan N, Wu J, Porcellati G, Sun AY (editors) (1983). Neuronal Membranes. Clifton, NJ: Humana Press.
69. Tay A, Simon JS, Squire J, Hamel K, Jacob HJ, Skorecki K (1995). Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers. Genomics 26:138-141.
70. Tsuang MT, Faraone SV, Lyons MJ (1993). Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatr Clin Neurosci 243:131-142.
71. Walker NP, Fox HC, Whalley LJ (1999). Lipids and schizophrenia. Br J Psychiatry 174:101-104.
72. World Health Organization (1992). Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Geneva: World Health Organization.
73. Xu W, Gorman P, Sheer D, Bates G, Kishimoto J, Lizhi L, Emson P (1993). Regional localization of the gene coding for human brain nitric oxide synthase (NOS1) to 12q24.2→24.31 by fluorescent in situ hybridization. Cytogenet Cell Genet 64:62-63.
74. Yagami T, Ueda K, Asakura K, Hayasaki-Kajiwara Y, Nakazato H, Sakaeda T, et al. (2002). Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. J Neurochem 8:449-461.